Floatz logo

Mpc-6827

Neurodegenerative Diseases

Columbia UniversityEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

21 Active assets in the Neurodegenerative Diseases cohort.

Asset / SponsorPhaseRating
Live Combined Bifidobacterium
Beijing Friendship Hospital
Phase 4BB
Live Combined Bifidobacterium,Lactobacillus And Enterococcus Capsules
Beijing Friendship Hospital
Phase 4BB
Lipitor
Monash University
Phase 4BB
Acp-103
Vanderbilt University Medical Center
Phase 4BB
LEVODOPA
Merck Sharp & Dohme LLC
Phase 2B

View all 41 →

Same molecule, other indications

Mpc-6827 is also rated in:

Glioblastoma MultiformeDormant
BB
Indicative ·
64 / 100
View asset →
Metastatic MelanomaDormant
CC
Indicative ·
46 / 100
View asset →
Refractory Solid TumorsDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →